Published in Arch Biochem Biophys on March 01, 1972
The properties of subunits of avidin coupled to sepharose. Biochem J (1973) 1.42
Refolding of triose phosphate isomerase. Biochem J (1973) 1.19
Affinity Chromatography of the Major Seed Protein of the Bean (Phaseolus vulgaris L.). Plant Physiol (1976) 0.93
Kinetic and molecular properties of citraconyl-aldolase. The reversible denaturation and hybridization of the native and modified enzymes. Biochem J (1974) 0.90
Urea-induced inactivation and denaturation of clostridial glutamate dehydrogenase: the absence of stable dimeric or trimeric intermediates. Biochem J (1995) 0.89
Disruption of the aldolase A tetramer into catalytically active monomers. Proc Natl Acad Sci U S A (1996) 0.87
Subunit interactions in tyrosinase from frog epidermis in immobilized enzyme systems. Biochem J (1981) 0.81
Incidence of diabetes among postmenopausal breast cancer survivors. Diabetologia (2012) 1.55
Rapid identification of subtype-selective agonists of the somatostatin receptor through combinatorial chemistry. Science (1998) 1.36
Design and biological activities of L-163,191 (MK-0677): a potent, orally active growth hormone secretagogue. Proc Natl Acad Sci U S A (1995) 1.32
Matrix-bound protein subunits. Biochem Biophys Res Commun (1970) 1.15
High-level expression and mutagenesis of recombinant human phosphatidylcholine transfer protein using a synthetic gene: evidence for a C-terminal membrane binding domain. Biochemistry (2000) 1.12
The aetiology of heart failure in the Chinese population of Hong Kong--a prospective study of 730 consecutive patients. Int J Cardiol (1995) 1.07
A nonpeptidyl growth hormone secretagogue. Science (1993) 1.04
Separation and properties of isozymes of 3-deoxy-D-arabino-heptulosonate-7-phosphate synthetase from Saccharomyces cerevisiae. Can J Biochem (1971) 1.00
Studies on protein subunits. 3. Kinetic evidence for the presence of active subunits during the renaturation of muscle aldolase. J Biol Chem (1973) 1.00
Bisphosphonates and osteoporotic fractures: a cross-design synthesis of results among compliant/persistent postmenopausal women in clinical practice versus randomized controlled trials. Osteoporos Int (2009) 0.97
The synergistic effects of His-D-Trp-Ala-Trp-D-Phe-Lys-NH2 on growth hormone (GH)-releasing factor-stimulated GH release and intracellular adenosine 3',5'-monophosphate accumulation in rat primary pituitary cell culture. Endocrinology (1989) 0.97
Active subunits of transaldolase bound to sepharose. Eur J Biochem (1973) 0.93
A novel 3-substituted benzazepinone growth hormone secretagogue (L-692,429). J Med Chem (1994) 0.93
Aconitine poisoning due to Chinese herbal medicines: a review. Vet Hum Toxicol (1994) 0.93
A complex between the catalytic and regulatory subunits of aspartate transcarbamylase. J Biol Chem (1973) 0.92
The effect of transcutaneous electrical nerve stimulation on coronary and systemic haemodynamics in syndrome X. Coron Artery Dis (1996) 0.91
Effect of low dose beta blockers on atrial and ventricular (B type) natriuretic factor in heart failure: a double blind, randomised comparison of metoprolol and a third generation vasodilating beta blocker. Br Heart J (1995) 0.89
Inhibition of leucine aminopeptidase by amino acid hydroxamates. J Biol Chem (1982) 0.89
Requirement of lysine residues outside of the proposed pentasaccharide binding region for high affinity heparin binding and activation of human antithrombin III. J Biol Chem (1996) 0.89
Effects of subunit interactions on the activity of lactate dehydrogenase studied in immobilized enzyme systems. Biochemistry (1976) 0.87
Subunit interactions in aspartate transcarbamylase. A model for the allosteric mechanism. J Biol Chem (1975) 0.86
Evidence for a role of protein kinase-C in His-D-Trp-Ala-Trp-D-Phe-Lys-NH2-induced growth hormone release from rat primary pituitary cells. Endocrinology (1991) 0.86
Purification and properties of phosphoprotein phosphatases with different substrate and divalent cation specificities from canine heart. Eur J Biochem (1978) 0.85
Multiple sites and synergism in the binding of inhibitors to microsomal aminopeptidase. Biochemistry (1988) 0.85
Some experimental approaches for studying subunit interactions in enzymes. Can J Biochem (1976) 0.85
Synergistic binding of inhibitors to the protease from HIV type 1. Biochem J (1996) 0.84
Analysis of the interactions between an enzyme and multiple inhibitors using combination plots. Biochem J (1996) 0.84
A method for the complete S sulfonation of cysteine residues in proteins. Biochemistry (1968) 0.83
On the mechanism of assembly of the aspartate transcarbamoylase from Escherichia coli. Eur J Biochem (1978) 0.83
Co-purification of type I alkaline phosphatase and type I phosphoprotein phosphatase from various animal tissues. Arch Biochem Biophys (1981) 0.83
Affinity chromatography of a regulatory enzyme based on specific interaction with the effector. Biochem Biophys Res Commun (1969) 0.83
Immobilized subunits. Methods Enzymol (1976) 0.82
Subunit interactions in aspartate transcarbamylase. Characterization of a complex between the catalytic and the regulatory subunits. J Biol Chem (1975) 0.82
Ligand interactions at the active site of aspartate transcarbamoylase from Escherichia coli. Biochemistry (1986) 0.82
Synergistic binding of hydrophobic probes and zinc ligands to thermolysin. Eur J Biochem (1993) 0.82
Stimulation of growth hormone release from rat primary pituitary cells by L-692,429, a novel non-peptidyl GH secretagogue. Endocrinology (1993) 0.81
Phosphorus-containing inhibitors of aspartate transcarbamoylase from Escherichia coli. FEBS Lett (1990) 0.81
Structure and function of aspartate transcarbamoylase studied using chymotrypsin as a probe. Can J Biochem (1978) 0.81
Synergistic binding of ligands to angiotensin-converting enzyme. J Biol Chem (1988) 0.81
Studies on protein subunits. V. Specific interaction between matrix-bound subunits of aldolase and soluble aldolase subunits. Can J Biochem (1973) 0.80
Oral treatment of peritonitis in CAPD patients with ofloxacin. Nephrol Dial Transplant (1988) 0.80
Inhibition of L-692,429-stimulated rat growth hormone release by a weak substance P antagonist: L-756,867. J Endocrinol (1997) 0.80
Stabilization of the relaxed state of aspartate transcarbamoylase by modification with a bifunctional reagent. J Biol Chem (1978) 0.80
Continuous spectrophotometric assay of a sepharose-bound enzyme and its use to study kinetics of coupling of the enzyme to sepharose. Anal Biochem (1973) 0.79
Improved prognosis since 1969 of myocardial infarction treated in a coronary care unit: lack of relation with changes in severity. BMJ (1989) 0.79
Oral treatment of peritonitis in CAPD patients with two dosage regimens of ofloxacin. J Antimicrob Chemother (1988) 0.79
Subunit interactions in aspartate trancarbamylase from Escherichia coli studied using matrix-bound derivatives. FEBS Lett (1974) 0.78
L-leucinthiol - a potent inhibitor of leucine aminopeptidase. Biochem Biophys Res Commun (1983) 0.78
Further studies on aspartate transcarbamoylase: molecular weight of the c3r6 complex and analysis of succinate inhibition in the native enzyme. Can J Biochem (1976) 0.78
Conformation of cross-linked aspartate transcarbamoylase. Can J Biochem (1981) 0.78
Subunit interactions in aspartate transcarbamylase. The interaction between catalytic and regulatory subunits and the effect of ligands. J Biol Chem (1975) 0.77
A novel non-peptidyl growth hormone secretagogue. Horm Res (1993) 0.77
Effect of lipoic acid on redox state of coenzyme Q in mice treated with 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine and diethyldithiocarbamate. Eur J Pharmacol (1994) 0.77
Topography of preemptying ventricular segments in patients with Wolff-Parkinson-White syndrome using scintigraphic phase mapping and esophageal pacing. Circulation (1983) 0.77
Conformations of bound nucleoside triphosphate effectors in aspartate transcarbamylase. Evidence for the London-Schmidt model by transferred nuclear Overhauser effects. Biochemistry (1985) 0.76
Functional changes in cocultures of mesencephalon and striatal neurons from embryonic C57/BL6 mice due to low concentrations of 1-methyl-4-phenylpyridinium (MPP+). J Neural Transm Gen Sect (1993) 0.76
Conformational states of aspartate transcarbamoylase stabilized with a cross-linking reagent. J Biol Chem (1979) 0.76
Nonpeptidyl somatostatin agonists demonstrate that sst2 and sst5 inhibit stimulated growth hormone secretion from rat anterior pituitary cells. Biochem Biophys Res Commun (1999) 0.76
Acyclic structural variants of growth hormone secretagogue L-692,429. Bioorg Med Chem Lett (1999) 0.76
Effects of electroacupuncture and gonadotropin-releasing hormone treatments on hormonal changes in anoestrous sows. Am J Chin Med (1988) 0.76
Electrical off response of cat esophageal smooth muscle: an analog simulation. Am J Physiol (1976) 0.76
Characteristics of fetal heart rate changes during the expulsive stage of bovine parturition in relation to fetal outcome. Am J Vet Res (1996) 0.76
Studies of the potentially endogenous toxin TaClo (1-trichloromethyl-1,2,3,4-tetrahydro-beta-carboline) in neuronal and glial cell cultures. J Neural Transm Suppl (1995) 0.75
Transoesophageal echocardiography. Postgrad Med J (1997) 0.75
Influence of labor and neonatal hypoxia on sympathoadrenal activation and methionine enkephalin release in calves. Am J Vet Res (1993) 0.75
Hybrid aspartate transcarbamoylase containing cross-linked subunits. Can J Biochem (1981) 0.75
Gem-dialkyl succinic acids: a novel class of inhibitors for carboxypeptidases. Biochemistry (1997) 0.75
Structural requirements for specific inhibition of microsomal aminopeptidase by mercaptoamines. Arch Biochem Biophys (1985) 0.75
Aspartate transcarbamoylase: loss of homotropic but not heterotropic interactions upon modification of the catalytic subunit with a bifunctional reagent. Can J Biochem (1979) 0.75
Imaging performance of the liquid-crystal-adaptive lens with conductive ladder meshing. Appl Opt (1997) 0.75
Chemical stabilization of conformational states of aspartate transcarbamoylase. Methods Enzymol (1987) 0.75
Activation of brain calcineurin towards proteins containing Thr(P) and Ser(P) by Ca2+, calmodulin, Mg2+ and transition metal ions. Eur J Biochem (1984) 0.75
Effects of L-deprenyl and amantadine in an MPTP-model of parkinsonism. J Neural Transm Suppl (1990) 0.75
Eskimos and multiple sclerosis. Lancet (1977) 0.75
Contribution of subunit interactions to the stability of lactate dehydrogenase. J Biol Chem (1977) 0.75
Multiple sclerosis and dogs. Lancet (1977) 0.75
Control of preweaning diarrhea in piglets by acupuncture and Chinese medicine. Am J Chin Med (1988) 0.75
Modeling directed design and biological evaluation of quinazolinones as non-peptidic growth hormone secretagogues. Bioorg Med Chem Lett (2000) 0.75
Pituitary adenylate cyclase activating polypeptide-induced desensitization on growth hormone release from rat primary pituitary cells. Biochem Biophys Res Commun (1993) 0.75
Formation of dissociated enzyme subunits by chemical treatment during renaturation. J Mol Biol (1974) 0.75
A potent, orally bioavailable benzazepinone growth hormone secretagogue. J Med Chem (1998) 0.75
Potent 3-spiropiperidine growth hormone secretagogues. Bioorg Med Chem Lett (1998) 0.75
Dissociation of phosphohistone phosphatases from canine heart. Biochim Biophys Acta (1977) 0.75
Synthesis and biological activities of spiroheterocyclic growth hormone secretagogues. Bioorg Med Chem Lett (1999) 0.75
Tripeptide growth hormone secretagogues. Bioorg Med Chem Lett (1998) 0.75
Isolation of DAHP synthetase by tyrosine-affinity chromatography. Methods Enzymol (1974) 0.75
Combined pacing and percutaneous closing device therapy for dilated cardiomyopathy and patent ductus arteriosus. Heart (2001) 0.75
PMA-sensitive protein kinase C is not necessary in TRH-stimulated prolactin release from female rat primary pituitary cells. Life Sci (1992) 0.75
Some properties of aminopeptidase associated with rat brain cortical synaptosomes. Can J Biochem Cell Biol (1983) 0.75
A case of acute aconitine poisoning caused by chuanwu and caowu. J Trop Med Hyg (1993) 0.75
Synthesis and biological activities of phenyl piperazine-based peptidomimetic growth hormone secretagogues. Bioorg Med Chem Lett (1998) 0.75
Organic reactions in aqueous solution at room temperature. IV. In vitro oxidation of a benzylisoquinoline alkaloid to an aporphine alkaloid. J Chem Soc Perkin 1 (1966) 0.75
Ofloxacin pharmacokinetics in patients on continuous ambulatory peritoneal dialysis. Clin Nephrol (1987) 0.75
An assay for ribonucleotide reductase based on ion-exchange chromatography of the reaction product. Anal Biochem (1985) 0.75